FHIT

Revision as of 16:24, 17 June 2014 by Rim Halaby (talk | contribs) (Created page with "__NOTOC__ {{SI}} {{CMG}} {{SK}} Fragile histidine triad; bis(5'-adenosyl)-triphosphatase, human accelerated region 10 ==Overview== Fragile histidine triad protein (FHIT) is ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for FHIT

Articles

Most recent articles on FHIT

Most cited articles on FHIT

Review articles on FHIT

Articles on FHIT in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on FHIT

Images of FHIT

Photos of FHIT

Podcasts & MP3s on FHIT

Videos on FHIT

Evidence Based Medicine

Cochrane Collaboration on FHIT

Bandolier on FHIT

TRIP on FHIT

Clinical Trials

Ongoing Trials on FHIT at Clinical Trials.gov

Trial results on FHIT

Clinical Trials on FHIT at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on FHIT

NICE Guidance on FHIT

NHS PRODIGY Guidance

FDA on FHIT

CDC on FHIT

Books

Books on FHIT

News

FHIT in the news

Be alerted to news on FHIT

News trends on FHIT

Commentary

Blogs on FHIT

Definitions

Definitions of FHIT

Patient Resources / Community

Patient resources on FHIT

Discussion groups on FHIT

Patient Handouts on FHIT

Directions to Hospitals Treating FHIT

Risk calculators and risk factors for FHIT

Healthcare Provider Resources

Symptoms of FHIT

Causes & Risk Factors for FHIT

Diagnostic studies for FHIT

Treatment of FHIT

Continuing Medical Education (CME)

CME Programs on FHIT

International

FHIT en Espanol

FHIT en Francais

Business

FHIT in the Marketplace

Patents on FHIT

Experimental / Informatics

List of terms related to FHIT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Fragile histidine triad; bis(5'-adenosyl)-triphosphatase, human accelerated region 10

Overview

Fragile histidine triad protein (FHIT) is an enzyme that in humans is encoded by the FHIT gene.[1][2] FHIT is also known as human accelerated region 10; it may, therefore, have played a key role in differentiating humans from apes.[3] FHIT gene, a member of the histidine triad gene family, encodes a diadenosine P1,P3-bis(5'-adenosyl)-triphosphate adenylohydrolase involved in purine metabolism. The gene encompasses the common fragile site FRA3B on chromosome 3, where carcinogen-induced damage can lead to translocations and aberrant transcripts of this gene. In fact, aberrant transcripts from this gene have been found in about half of all esophageal, stomach, and colon carcinomas.[4] Although the exact molecular function of FHIT is still partially unclear, the gene works as a tumor suppressor as it has been demonstrated in animal studies.[5][6][7] Furthermore FHIT has been shown to synergize with VHL, another tumor suppressor, in protecting against chemically - induced lung cancer.[8] FHIT also acts as a tumor suppressor of HER2/neu driven breast cancer.[9] FHIT has been shown to interact with UBE2I.[10]

References

  1. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (Apr 1996). "The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers". Cell. 84 (4): 587–97. doi:10.1016/S0092-8674(00)81034-X. PMID 8598045.
  2. Pekarsky Y, Campiglio M, Siprashvili Z, Druck T, Sedkov Y, Tillib S, Draganescu A, Wermuth P, Rothman JH, Huebner K, Buchberg AM, Mazo A, Brenner C, Croce CM (Aug 1998). "Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans". Proc Natl Acad Sci U S A. 95 (15): 8744–9. doi:10.1073/pnas.95.15.8744. PMC 21147. PMID 9671749.
  3. Pollard KS, Salama SR, Lambert N, Lambot MA, Coppens S, Pedersen JS, Katzman S, King B, Onodera C, Siepel A, Kern AD, Dehay C, Igel H, Ares M Jr, Vanderhaeghen P, Haussler D (2006-08-16). "An RNA gene expressed during cortical development evolved rapidly in humans". Nature. 443 (7108): 167–172. doi:10.1038/nature05113. PMID 16915236. supplement
  4. "Entrez Gene: FHIT fragile histidine triad gene".
  5. Fong LY, Fidanza V, Zanesi N, Lock LF, Siracusa LD, Mancini R, Siprashvili Z, Ottey M, Martin SE, Druck T, McCue PA, Croce CM, Huebner K (April 2000). "Muir-Torre-like syndrome in Fhit-deficient mice". Proc. Natl. Acad. Sci. U.S.A. 97 (9): 4742–7. doi:10.1073/pnas.080063497. PMC 18303. PMID 10758156.
  6. Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rüdiger T, McCue PA, Croce CM, Huebner K (August 2001). "The tumor spectrum in FHIT-deficient mice". Proc. Natl. Acad. Sci. U.S.A. 98 (18): 10250–5. doi:10.1073/pnas.191345898. PMC 56947. PMID 11517343.
  7. Zanesi N, Pekarsky Y, Croce CM (December 2005). "A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention". Mutat. Res. 591 (1–2): 103–9. doi:10.1016/j.mrfmmm.2005.05.016. PMID 16085127.
  8. Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner K (August 2005). "Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency". Cancer Res. 65 (15): 6576–82. doi:10.1158/0008-5472.CAN-05-1128. PMID 16061637.
  9. Bianchi F, Tagliabue E, Ménard S, Campiglio M (March 2007). "Fhit expression protects against HER2-driven breast tumor development: unraveling the molecular interconnections". Cell Cycle. 6 (6): 643–6. doi:10.4161/cc.6.6.4033. PMID 17374991.
  10. Shi Y, Zou M, Farid NR, Paterson MC (December 2000). "Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9". Biochem. J. 352 (2): 443–8. doi:10.1042/0264-6021:3520443. PMC 1221476. PMID 11085938.